Medicenna Therapeutics Corp (MDNA : TSX)
Common Stock
$0.41
CAD
+0.02 (5.13%)
Last updated: 2026-10-21
Follow MDNA
MDNA
Medicenna Therapeutics Corp
WealthAwesomePerformance
1 Day
+5.13%
1 Week
-6.82%
1 Month
-3.53%
YTD
-59.00%
Key Statistics
Market Cap
$37.84M
52W High
$1.97
52W Low
$0.34
P/E Ratio
-
50 Day MA
$0.43
200 Day MA
$0.57
Beta
2.10
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/21/2026 | $0.39 | $0.42 | $0.39 | $0.41 | $0.41 | 89,293 |
| 10/20/2026 | $0.39 | $0.40 | $0.39 | $0.39 | $0.39 | 53,508 |
| 10/19/2026 | $0.45 | $0.45 | $0.39 | $0.41 | $0.41 | 96,838 |
| 10/16/2026 | $0.44 | $0.45 | $0.44 | $0.45 | $0.45 | 20,028 |
| 10/15/2026 | $0.45 | $0.45 | $0.44 | $0.44 | $0.44 | 10,650 |
| 10/14/2026 | $0.45 | $0.45 | $0.42 | $0.44 | $0.44 | 8,815 |
| 10/13/2026 | $0.45 | $0.46 | $0.43 | $0.43 | $0.43 | 94,356 |
| 10/9/2026 | $0.43 | $0.43 | $0.43 | $0.43 | $0.43 | 3,000 |
| 10/8/2026 | $0.45 | $0.46 | $0.43 | $0.45 | $0.45 | 44,681 |
| 10/7/2026 | $0.43 | $0.45 | $0.43 | $0.45 | $0.45 | 23,838 |
Analyst Price Targets
Based on analyst covering MDNA · as of Sep 17, 2026
Wall Street analysts forecast MDNA stock price to rise 680.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+680.5% Upside
Current Price
C$0.41
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
56.3%
Annualized
90-Day Vol
53.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.49
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.44 | C$0.36 – C$0.53 |
| 60 trading days | C$0.46 | C$0.35 – C$0.61 |
| 90 trading days | C$0.49 | C$0.35 – C$0.69 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Medicenna Therapeutics Corp
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, an interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; and MDNA113, a tumor-targeting and activatable bifunctional anti-PD-1-IL-2 superkine for cancer. In addition, its preclinical products are MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases, including transplant rejection; and MDNA413, an IL-4/IL-13 antagonist to inflammatory, asthma, and atopic dermatitis, as well as other allergic diseases. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-22.36M
- Profit Margin
- 0.00%
- ROE (TTM)
- -227.57%
- EPS (Diluted)
- -0.22
- Book Value
- 0.02
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MDNA
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
MDNA.TO news timeline
15 articles covering MDNA.TO, most recent first
LatestWhy Medicenna Therapeutics Corp stock is rising today
October 2026
September 2026
- What's Going On With Medicenna Therapeutics Corp Stock Thursday?
- Why Medicenna Therapeutics Corp stock fell yesterday
- What's Going On With Medicenna Therapeutics Corp Stock Wednesday?
- Why Medicenna Therapeutics Corp stock fell yesterday
- Why Medicenna Therapeutics Corp stock plummeted yesterday
- What's Going On With Medicenna Therapeutics Corp Stock Wednesday?